Products & Services · Percent Change (as a percent)

SURGICAL — Percent Change (as a percent)

Johnson & Johnson SURGICAL — Percent Change (as a percent) increased by 1112.5% to 9.7% in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 162.2%, from 3.7% to 9.7%. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ1 2018
Last reportedQ1 2026Apr 22, 2026

How to read this metric

A positive percentage indicates segment expansion and strong commercial execution, whereas a negative percentage suggests a contraction in market share or a slowdown in surgical procedure volumes.

Detailed definition

This metric measures the period-over-period growth rate of revenue generated by the surgical products segment, expressed...

Peer comparison

Comparable to organic or reported segment revenue growth rates disclosed by peers in the medical technology and surgical equipment sectors.

Metric ID: jnj_segment_surgical_percent_change_as_a_percent

Historical Data

17 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value39.1%22.7%20.4%10.5%-3.2%0.1%6.2%10.3%0.3%-0.5%1.3%2.9%3.7%9.9%14.9%0.8%9.7%
QoQ Change-41.9%-10.1%-48.5%-130.5%+103.1%>999%+66.1%-97.1%-266.7%+360.0%+123.1%+27.6%+167.6%+50.5%-94.6%>999%
YoY Change-73.1%-114.1%-99.5%-41.0%+421.9%+200.0%-108.1%-87.4%>999%>999%>999%-72.4%+162.2%
Range-3.2%39.1%
CAGR-29.4%
Avg YoY Growth+342.2%
Median YoY Growth-41.0%

Frequently Asked Questions

What is Johnson & Johnson's surgical — percent change (as a percent)?
Johnson & Johnson (JNJ) reported surgical — percent change (as a percent) of 9.7% in Q1 2026.
How has Johnson & Johnson's surgical — percent change (as a percent) changed year-over-year?
Johnson & Johnson's surgical — percent change (as a percent) increased by 162.2% year-over-year, from 3.7% to 9.7%.
What does surgical — percent change (as a percent) mean?
The percentage growth or decline in surgical product revenue compared to the previous period.